World Health Organization guidelines panel advised against using the antiviral remdesivir for hospitalized patients, saying there’s no evidence it improves survival or avoids the need for breathing machines.
The Supreme Court Thursday sought response from the Centre on a plea alleging that two medicines Remdesivir and Favipiravir, are being used for treatment of COVID-19 without approval.
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.
US President Donald Trump, who was shifted to a military hospital after being tested positive for COVID-19, is undergoing Remdesivir therapy and is "doing well", the White House physician has said
A batch of Remdesivir for treatment of COVID-19 patients has been withdrawn in view of 'sub-standard quality' of the medicine, Maharashtra Health Minister Rajesh Tope said on Wednesday.
Dr. Reddys Laboratories Ltd on Wednesday announced the launch of Remdesivir, meant for treatment of COVID-19 patients, under a brand name 'Redyx' in India.
Cadila Health's Zydus Cadila on Thursday launched the cheapest generic version of Gilead Sciences’ antiviral drug in India, to treat COVID-19. Called as Remdac (Remdesivir), the drug has been launched following reports of shortages at drugs at various hospitals.
The company will make the drug available to over 1,000 hospitals providing COVID-19 treatment, Jubilant Life Sciences said in a statement.
The Union health ministry has asked the Drugs Controller General of India to ensure equitable distribution of Remdesivir and Tocilizumab drugs, which have been included as "investigational therapies" in the national treatment protocols for COVID-19, across the country.
Canada has announced its authorisation for using the drug remdesivir for treating patients suffering severe symptoms of Covid-19 who have pneumonia and require extra oxygen to help them breathe.
The police on Wednesday arrested several persons in connection with black marketing of Remdesivir and Tocilizumab injections, used in Covid-19 treatment.
Two life-saving drugs used to treat Covid-19 patients in India - remdesivir and tocilizumab - are in short supply and being sold for excessive rates on a thriving black market.
Noida-headquartered Jubilant Life Science has reportedly received permission to manufacture Remdesivir for emergency use with same conditions as given to other companies like Hetero, Cipla and Mylan.
Pharma major Mylan on Monday said it has commercially launched the generic version of Remdesivir drug under the brand name 'Desrem' in India for treatment of coronavirus patients.
Covifor is the first generic brand of Remdesivir, which is meant for treatment of COVID-19 patients that are adults and children, hospitalised with severe symptoms of the disease.
Rumours spread in Mumbai on 'coronavirus vaccine'. Following this, people started gathering at a store in Ghatkopar.
The Indian Council of Medical Research (ICMR) and the All India Institute of Medical Sciences (AIIMS) have asked states to use drugs like remdesivir and tocilizumab, mentioned as investigational therapies, on COVID-19 patients strictly as per the laid down protocol as their "indiscriminate use or use in conditions for which they are not desirable may cause more harm than good".
New data revealed by Gilead Sciences has shown that its antiviral drug remdesivir reduces death risk of severe Covid-19 patients by as much as 62 per cent when compared with standard care alone.
Doctors in state hospitals are being advised to use antiviral Remdesivir on COVID-19 patients strictly as per protocol amid some reports of liver damage in such patients treated with the drug, official sources said.
Several cities across India, including Mumbai, Bangalore are reportedly facing a shortage of the experimental antiviral drug Remdesivir. Delhi is also struggling to source it from other cities or buying it at exorbitant prices. In Delhi, both private and government hospitals have reported depleting stock of the coronavirus medicine.
Top News
Latest News
